{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:29:48Z","timestamp":1782818988454,"version":"3.54.5"},"reference-count":22,"publisher":"Japanese Urological Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2018,4,20]]},"DOI":"10.5980\/jpnjurol.109.59","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T22:09:13Z","timestamp":1555625353000},"page":"59-67","source":"Crossref","is-referenced-by-count":2,"title":["OUTCOME OF BLADDER PRESERVATION USING LOW DOSE CHEMORADIATION THERAPY IN PATIENTS WITH LOCALLY INVASIVE BLADDER CANCER","\u5f53\u9662\u306b\u304a\u3051\u308b\u5c40\u6240\u6d78\u6f64\u6027\u8180\u80f1\u764c\u306b\u5bfe\u3059\u308b\u4f4e\u7dda\u91cf\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306e\u6cbb\u7642\u6210\u7e3e"],"prefix":"10.5980","volume":"109","author":[{"given":"Makoto","family":"Matsushita","sequence":"first","affiliation":[{"name":"Department of Urology, Sumitomo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kitakaze","sequence":"additional","affiliation":[{"name":"Department of Urology, Sumitomo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Urology, Sumitomo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Minato","sequence":"additional","affiliation":[{"name":"Department of Urology, Nissay Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Urology, Sumitomo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Urology, Sumitomo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kitamura H, Tsukamoto T, Shibata T, Masumori N, Fujimoto H, Hirao Y, Fujimoto K, Kitamura Y, Tomita Y, Tobisu K, Niwakawa M, Naito S, Eto M and Kakehi Y: Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209. Ann Oncol, 25, 1192-1198, 2014.","DOI":"10.1093\/annonc\/mdu126"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Adovanced Bladder Cancer (ABC) Meta-analysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer; update of a systematic review and meta-analysis of individual patient date adovanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol, 48 (2), 202-206, 2005.","DOI":"10.1016\/j.eururo.2005.04.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tester W, Poster A, Asbell S, Couqhlin C, Heaney J, Krall J, Martz K, Venner P and Hammond E: Combined modality program with possible organ preservation for invasive bladder carcinoma results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys, 25, 783-790, 1993.","DOI":"10.1016\/0360-3016(93)90306-G"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tunio MA, Hashmi A, Qayyum A, Mohsin R and Zaeem A: Whole-pelvis or bladder-only chemoradiation for lymph node-negative invasive bladder cancer: single-institution experience. Int J Radiat Oncol Biol Phys, 82, 457-462, 2012.","DOI":"10.1016\/j.ijrobp.2011.05.051"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Weiss C, Engehausen DG, Krause FS, Papadopoulos T, Dunst J, Sauer R and Rodel C: Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer. Int J Radiat Oncol Biol Phys, 68, 1072-1080, 2007.","DOI":"10.1016\/j.ijrobp.2007.01.054"},{"key":"6","doi-asserted-by":"crossref","unstructured":"8) Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D and Skinner DG: Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol, 19, 666-675, 2001.","DOI":"10.1200\/JCO.2001.19.3.666"},{"key":"7","doi-asserted-by":"crossref","unstructured":"9) Hautmann RE, dePetriconi RC, Pfeiffer C and Volkmer BG: Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol, 61, 1039-1047, 2012.","DOI":"10.1016\/j.eururo.2012.02.028"},{"key":"8","doi-asserted-by":"crossref","unstructured":"10) Blake MA and Kalra MK: Imaging of urinary tract tumors. Cancer Treat Res, 143, 259-317, 2008.","DOI":"10.1007\/978-0-387-75587-8_12"},{"key":"9","doi-asserted-by":"crossref","unstructured":"11) Green DA, Durand M, Gumpeni N, Rink M, Cha EK, Karakiewicz PI, Scherr DS and Shariat SF: Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. BJU Int, 110, 1463-1470, 2012.","DOI":"10.1111\/j.1464-410X.2012.11129.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"12) Shiplely WU, Winter KA, Kaufman DS, Lee WR, Heney NM, Tester WR, Donnelly BJ, Venner PM, Perez CA, Murray KJ, Doqqett RS and True LD: Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol, 16, 3576-3583, 1998.","DOI":"10.1200\/JCO.1998.16.11.3576"},{"key":"11","doi-asserted-by":"crossref","unstructured":"13) Housset M, Maulard C, Chretien Y, Dufour B, Delanian S, Huart J, Colardelle F, Brunel P and Baillet F: Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol, 11, 2150-2157, 1993.","DOI":"10.1200\/JCO.1993.11.11.2150"},{"key":"12","doi-asserted-by":"crossref","unstructured":"14) Choudhury A, Swindell R, Lougue JP, Elliott PA, Livsey JE, Wise M, Symonds P, Wylie JP, Ramani V, Sangar V, Lyons J, Bottomley I, McCaul D, Clarke NW, Kiltie AE and Cowan RA: Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabione in muscle-invasive bladder cancer. J Clin Oncol, 29, 733-738, 2011.","DOI":"10.1200\/JCO.2010.31.5721"},{"key":"13","doi-asserted-by":"crossref","unstructured":"15) Kragelj B, Zaletel-Krageli L, Sedmak B, Cufer T and Cervek J: Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer. Radiother Oncol, 75, 44-47, 2005.","DOI":"10.1016\/j.radonc.2005.01.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"16) Rotman M, Aziz H, Porrazzo M, Choi KN, Silverstein M, Rosenthal J, Laungani G and Macchia R: Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion. Int J Radiat Oncol Biol Phys, 18, 1131-1137, 1990.","DOI":"10.1016\/0360-3016(90)90449-T"},{"key":"15","doi-asserted-by":"crossref","unstructured":"17) Russell KJ, Boileau MA, Higano C, Collins C, Russell AH, Koh W, Cole SB, Chapman WH and Griffin TW: Combind 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys, 19, 693-699, 1990.","DOI":"10.1016\/0360-3016(90)90498-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"18) James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, Crundwell M, Sizer B, Sreenivasan T, Hendron C, Lewis R, Waters R and Huddart RA; BC2001 Investigators: Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med, 366, 1477-1488, 2012.","DOI":"10.1056\/NEJMoa1106106"},{"key":"17","doi-asserted-by":"publisher","unstructured":"19) Mokarim A, Utani M, Hayashi N, Sakamoto I, Minami K, Ogawa Y, Ochi M, Matsuoka Y, Hayashi K and Nomata K: Combined intraarterial chemotherapy and radiotherapy in the treatment of bladder carcinoma. Cancer, 80, 1776-1785, 1997.","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1776::AID-CNCR12>3.0.CO;2-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"20) Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y and Kataoka M: Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer. Jpn J Clin Oncol, 39, 381-386, 2009.","DOI":"10.1093\/jjco\/hyp023"},{"key":"19","doi-asserted-by":"crossref","unstructured":"21) Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Uehara H, Komura K, Minami K, Kouno J, Kotake Y, Abe H, Takagi S, Ibuki N, Yamamoto K, Narumi Y and Kiyama S: A great option for elderly patients with locally invasive bladder cancer. BOAI-CDDP-radiation (OMC regimen). Int J Oncol, 43, 1087-1094, 2013.","DOI":"10.3892\/ijo.2013.2058"},{"key":"20","doi-asserted-by":"crossref","unstructured":"22) Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Ibuki N, Uehara H, Komura K, Minami K, Uchimoto T, Saito K, Takai T, Tanda N, Yamamoto K, Narumi Y and Kiyama S: Novel bladder preservation therapy with Osaka Medical Collage regimen. J Urol, 193, 443-450, 2015.","DOI":"10.1016\/j.juro.2014.08.094"},{"key":"21","doi-asserted-by":"crossref","unstructured":"23) Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keeqan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Saqaloswky AI, Soloway MS and Stenzl A: ICUD-EAU International Consulation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol, 63, 45-57, 2013.","DOI":"10.1016\/j.eururo.2012.08.009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"24) Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, Rodel CM, Shariat SF, Shipley WU, Sternberg CN, Thalmann GN and Kassouf W: Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review. Eur Urol, 66, 120-137, 2014.","DOI":"10.1016\/j.eururo.2014.02.038"}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/109\/2\/109_59\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T03:45:19Z","timestamp":1555731919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/109\/2\/109_59\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.109.59","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]}}}